Skip to content
Clinical Trial Events
Follow

Get an email when they’re booked to speak.

All speakers

Alberto Sanchez-Fueyo, MD PhD

RW Institute of Liver Studies, Kings College London

Alberto Sanchez-Fueyo is Professor of Hepatology at King's College London University and founder of Quell Therapeutics Ltd. His research is focused in understanding the mechanisms of transplantation tolerance in the clinic and developing novel immunotherapeutic strategies.

1 talk

Speaking

Titles as listed at each event

2026